AMAG Pharmaceuticals, Inc. Bookmark and Share

ArticleDateSource
AMAG Pharmaceuticals, Inc. (AMAG) Announces Financial Results for the Second Quarter and Six Months Ended June 30, 20--Biotechnology - Moreover
AMAG Pharmaceuticals, Inc. Slumps as it Shelves Possible Sale May 11, 2012BioSpace
Amag Pharma falls after ending sale talksMay 10, 2012Health News - CNBC
AMAG Pharmaceuticals, Inc. Appoints as President and Chief Executive Officer May 10, 2012BioSpace - Breaking News
AMAG Pharmaceuticals Appoints William Heiden as President and Chief Executive OfficerMay 09, 2012Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Host Conference Call on May 1, 2012 at 4:30 p.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2012April 24, 2012Pharma News - Business Wire
EU committee recommends approval for Amag drugApril 20, 2012Health News - CNBC
Takeda y AMAG reciben una opinión positiva del CHMP en Europa sobre Rienso® (ferumoxytol)April 20, 2012Biotech News - PR Newswire
AMAG scores initial EU nod for anemia drugApril 20, 2012Health News - BizJournals.com
AMAG Pharmaceuticals, Inc. Announces Preliminary Results from its Phase III Study Evaluating Feraheme Compared to IV Iron Sucrose in Patients with Iron Deficiency Anemia March 08, 2012BioSpace - Breaking News
Amag Pharma says anemia drug works in studyMarch 07, 2012Health News - CNBC
AMAG Pharmaceuticals Announces Preliminary Results from its Phase III Study Evaluating Feraheme Compared to IV Iron Sucrose in Patients with Iron Deficiency AnemiaMarch 07, 2012FDA News - Business Wire
CORRECTING and REPLACING AMAG Pharmaceuticals, Inc. to Host Conference Call on March 7, 2012 at 4:30 p.m. ET to Discuss Feraheme Clinical Trial ResultsMarch 06, 2012Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Host Conference Call on March 7, 2012 at 4:30 p.m. ET to Discuss Feraheme Clinical Trial ResultsMarch 06, 2012Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Present at the 24th Annual ROTH ConferenceMarch 02, 2012Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Host Conference Call on March 5, 2012 at 4:30 p.m. ET to Discuss Financial Results for the Fourth Quarter and Year Ended 2011February 23, 2012Pharma News - Business Wire
AMAG Pharmaceuticals Announces the Appointment of Two Independent Directors to its BoardFebruary 07, 2012Pharma News - Business Wire
Research and Markets: Global Intravenous (IV) Iron Drugs Market: A Must-read Report Featuring Leading Players Such as Galenica, Watson and AMAG PharmaceuticalsFebruary 02, 2012Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. Announces Completion of Enrollment in its Phase III Program Evaluating Feraheme for a Broader Iron Deficiency Anemia Indication January 30, 2012BioSpace - Breaking News
AMAG Pharmaceuticals Announces Completion of Enrollment in its Phase III Program Evaluating Feraheme for a Broader Iron Deficiency Anemia IndicationJanuary 30, 2012Pharma News - Business Wire
AMAG predicts fourth quarter revenue to miss analyst estimatesJanuary 09, 2012Health News - BizJournals.com
AMAG sees Q4 revenue $14.3M-$15M vs. consensus $16.11MJanuary 09, 2012Pharmaceutical - Moreover
AMAG fourth quarter earnings miss analyst estimatesJanuary 09, 2012Health News - BizJournals.com
AMAG Pharmaceuticals, Inc. to Present at the 30th Annual J.P. Morgan Healthcare ConferenceJanuary 04, 2012Pharma News - Business Wire
Amag cleared to sell drug in CanadaDecember 13, 2011Pharmaceutical - Moreover
AMAG anemia drug heads to Great White NorthDecember 13, 2011Health News - BizJournals.com
AMAG Pharmaceuticals, Inc.,Takeda Pharmaceutical Co. Ltd.: Health Canada Approves Feraheme?? (ferumoxytol) to Treat Iron Deficiency Anemia in Adults with Chronic Kidney Disease December 12, 2011BioSpace
AMAG Pharmaceuticals Announces Preliminary Data Regarding the Safety and Efficacy of a Single Infusion of 1020 mg Ferumoxytol (Feraheme®) in Patients with Iron Deficiency AnemiaDecember 12, 2011Pharma News - Business Wire
Analyst: AMAG Pharma could see buyout offer from TakedaDecember 08, 2011Health News - BizJournals.com
AMAG Shares Zoom on CEO Departure and Re-Org PlansNovember 04, 2011Xconomy Life Sciences
AMAG CEO departs amid job cuts, failed mergerNovember 04, 2011Health News - BizJournals.com
AMAG Pharmaceuticals, Inc. Announces Financial Results for the Third Quarter Ended September 30, 2011 November 04, 2011BioSpace - Breaking News
AMAG Pharmaceuticals, Inc. Reschedules Third Quarter Financial Results Conference Call to November 4, 2011 at 8:00 a.m. ET November 04, 2011BioSpace - Breaking News
AMAG Announces Financial Results for the Third Quarter Ended September 30, 2011November 04, 2011Pharma News - Business Wire
MSMB Files Revised Preliminary Consent Solicitation Statement to Replace the Board of Directors of AMAG PharmaceuticalsNovember 02, 2011Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. Announces Data Presentations at the American Society of Nephrology Kidney Week 2011November 02, 2011Pharma News - Business Wire
AMAG and Allos Axe $686M Merger After Negative Vote from AMAG ShareholdersOctober 24, 2011Inside Industry - Gen
Allos Therapeutics, Inc., AMAG Pharmaceuticals, Inc. Merger Called Off October 21, 2011BioSpace
AMAG stockholders vote against merger with AllosOctober 21, 2011FiercePharma
AMAG Pharmaceuticals Announces Results of Special Stockholder Meeting Regarding Proposed MergerOctober 21, 2011Pharma News - Business Wire
Allos Therapeutics Announces Termination of Merger Agreement with AMAG PharmaceuticalsOctober 21, 2011Pharma News - Business Wire
AMAG Pharmaceuticals to Host Conference Call on October 21, 2011 at 10:00 a.m. ET to Discuss the Results of the Special Meeting of Stockholders VoteOctober 21, 2011Pharma News - Business Wire
Allos Therapeutics, Inc. Announces Settlement with Putative Class Action Plaintiffs Regarding Merger with AMAG Pharmaceuticals, Inc. October 14, 2011BioSpace - Breaking News
Allos Therapeutics Announces Settlement with Putative Class Action Plaintiffs Regarding Merger with AMAG PharmaceuticalsOctober 13, 2011Pharma News - Business Wire
MSMB Capital Announces that ISS Recommends that AMAG Shareholders Vote AGAINST the Allos TransactionOctober 11, 2011Pharma News - Business Wire
Allos Therapeutics, Inc. Continues to Work Toward Completion of Merger with AMAG Pharmaceuticals, Inc. October 10, 2011BioSpace - Breaking News
Allos Therapeutics: Amag merger plans still on; separate buyout offer is offOctober 10, 2011Health News - BizJournals.com
With third-party suitor out, AMAG merger fight heats upOctober 10, 2011Health News - BizJournals.com
Allos Therapeutics Continues to Work Toward Completion of Merger with AMAG PharmaceuticalsOctober 10, 2011Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. Urges Stockholders to Postpone Making Any Decision Regarding the Preliminary Consent SolicitationSeptember 26, 2011Biotechnology - Moreover
AMAG Pharma lays plans to halt board shakeupSeptember 26, 2011Health News - BizJournals.com
AMAG Pharmaceuticals Urges Stockholders to Postpone Making Any Decision Regarding the MSMB Capital Preliminary Consent Solicitation (BIZ)September 26, 2011Biotechnology - Moreover
AMAG Pharmaceuticals Urges Stockholders to Postpone Making Any Decision Regarding the MSMB Capital Preliminary Consent SolicitationSeptember 26, 2011Pharma News - Business Wire
MSMB Capital moves to oust Amag Pharma boardSeptember 22, 2011Health News - CNBC
After Yesterday's Decline of 1.41%, AMAG Pharmaceuticals Offers Investors Better Value (AMAG)September 15, 2011Biotechnology - Moreover
AMAG Pharmaceuticals, Inc. (AMAG) to Present at the BairdSeptember 08, 2011Biotechnology - Moreover
AMAG Pharmaceuticals, Inc. to Present at the Baird 2011 Healthcare ConferenceSeptember 07, 2011Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. Board of Directors Unanimously Opposes Unsolicited Proposal from August 09, 2011BioSpace - Breaking News
AMAG board opposes white knight bid, reaffirms mergerAugust 09, 2011Health News - BizJournals.com
AMAG Pharmaceuticals, Inc. Board of Directors Unanimously Opposes Unsolicited Proposal from MSMB CapitalAugust 08, 2011Pharma News - Business Wire
AMAG PHARMACEUTICALS IS AMONG THE COMPANIES IN THE BIOTECHNOLOGY INDUSTRY WITH ...August 05, 2011Biotechnology - Moreover
AMAG Pharma gets takeover bid to stop Allos mergerAugust 03, 2011Biotechnology - Moreover
AMAG Pharmaceuticals, Inc. Investor Makes $378 Million Takeover Bid for Firm to Stop Merger With Allos Therapeutics, Inc. August 03, 2011BioSpace
Hedge fund swoops in with $378M Amag bidAugust 03, 2011FiercePharma
AMAG investor out to derail Allos merger with buyout offerAugust 03, 2011FierceBiotech
AMAG Pharmaceuticals, Inc. Receives Unsolicited Proposal from August 03, 2011BioSpace - Breaking News
New York Hedge Fund Makes $378 Million Bid for Amag in Attempt to Block Poorly Received MergerAugust 03, 2011Xconomy Life Sciences
Amag Pharma receives unsolicited acquisition offerAugust 03, 2011Health News - CNBC
AMAG investor launches takeover bid to halt mergerAugust 03, 2011Health News - BizJournals.com
Amag Investor MSMB Makes $18 per Share Takeover Bid for Firm to Stop Merger with AllosAugust 03, 2011Inside Industry - Gen
AMAG Pharmaceuticals, Inc. Receives Unsolicited Proposal from MSMB Capital ManagementAugust 03, 2011Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. Appoints Frank E. Thomas as Executive Vice President and Chief Financial OfficerAugust 01, 2011Pharma News - Business Wire
After Yesterday's Decline of 1.65%, AMAG Pharmaceuticals Offers Investors Better Value (AMAG)July 29, 2011Biotechnology - Moreover
AMAG Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2011July 26, 2011Pharma News - Business Wire
AMAG Pharmaceuticals to Host Conference Call on July 26, 2011 at 4:30 p.m. ET to Discuss Financial Results for the Second Quarter and Six Months Ended June 30, 2011July 22, 2011Pharma News - Business Wire
Biogen Confirms Cambridge Move, Amag Merges With Allos, ACT Kicks Off Trials, & More Boston-Area Life Sciences NewsJuly 22, 2011Xconomy Life Sciences
Amag to buy Allos Therapeutics in all-stock dealJuly 20, 2011Health News - CNBC
Stocks in Play: AMAG Pharmaceuticals Inc. (Nasdaq: AMAG), Allos Therapeutics Inc. (Nasdaq: ALTH)July 20, 2011Biotechnology - Moreover
Amag Makes Good on Acquisition Promise, But Wall Street BalksJuly 20, 2011Xconomy Life Sciences
AMAG Pharmaceuticals, Inc., Allos Therapeutics, Inc. to Merge in $686 Million Deal July 20, 2011BioSpace
After struggles, AMAG Pharma to merge with Colo. biotechJuly 20, 2011Health News - BizJournals.com
AMAG and Allos to merge, readying the budget axeJuly 20, 2011FierceBiotech
AMAG Pharmaceuticals and Allos Therapeutics Agree to Merge to Strengthen Commercial Portfolio and Achieve Cost SynergiesJuly 20, 2011Pharma News - Business Wire
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences NewsJuly 15, 2011Xconomy Life Sciences
Amag Rebounds from FDA Handwringing, Looks To Stock Pipeline Through AcquisitionsJuly 12, 2011Xconomy Life Sciences
AMAG Pharma rises following upgradeMay 31, 2011Health News - CNBC
AMAG Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer May 26, 2011BioSpace - Breaking News
AMAG Pharmaceuticals Announces Resignation of Chief Financial OfficerMay 25, 2011Pharma News - Business Wire
AMAG tumbles as drug stocks trade flatMay 04, 2011Biotechnology - Moreover
AMAG tumbles in drug-sector tradingMay 04, 2011Biotechnology - Moreover
Amag stock sinks on poor drug salesMay 04, 2011Health News - BizJournals.com
AMAG Announces Financial Results for the First Quarter Ended March 31, 2011May 03, 2011Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Host Conference Call on May 3, 2011 at 4:30 p.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2011April 22, 2011Pharma News - Business Wire
AMAG Pharma opts for cloud over internal infrastructureApril 04, 2011FierceBiotech IT
AMAG Pharmaceuticals, Inc. (AMAG) Announces Fourth Quarter and Year End 20February 26, 2011Biotechnology - Moreover
Amag 4Q loss widens on costs, lower tax benefitFebruary 25, 2011Health News - CNBC
AMAG Announces Fourth Quarter and Year End 2010 Financial ResultsFebruary 25, 2011Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Host Conference Call on February 25, 2011 at 8:00 a.m. ET to Discuss Financial Results for the Fourth Quarter and Year Ended 2010February 18, 2011Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. Provides Update on Canadian New Drug Submission February 09, 2011BioSpace - Breaking News
AMAG Pharmaceuticals Provides Update on Canadian New Drug SubmissionFebruary 09, 2011Clinical Trials - Business Wire
AMAG Pharmaceuticals Provides Business UpdateJanuary 09, 2011Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Present at the 29th Annual J.P. Morgan Healthcare ConferenceJanuary 05, 2011Pharma News - Business Wire
Analyst Research on Immucor Inc. and AMAG Pharmaceuticals Inc. - Diagnostic Substances Sector Primed to GrowJanuary 05, 2011Marketwire - Pharma and Biotech
Canaccord Genuity Morning Coffee on AMAG Pharma AMAG Out of The Penalty BoxNovember 30, 2010Pharmaceutical - Moreover
AMAG Pharmaceuticals, Inc. Dodges ???Black Box??? FDA Warning on Anemia Drug, Feraheme November 30, 2010BioSpace
AMAG To Revise Feraheme Labeling Amid Safety ConcernsNovember 29, 2010Health News - Fox Business
Amag shares rise as Feraheme agreement announcedNovember 29, 2010Health News - CNBC
AMAG Soars On FDA UpdateNovember 29, 2010Health News - Fox Business
AMAG Pharma signs pact with FDA for Feraheme labelNovember 29, 2010Pharmaceutical - Moreover
AMAG Pharmaceuticals Announces Update to Feraheme® LabelNovember 29, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Host Conference Call on Monday, November 29, 2010 at 8:00 a.m. ET to Provide an Update on Feraheme Label DiscussionsNovember 26, 2010Pharma News - Business Wire
Palo Alto Investors Calls on Board of AMAG Pharmaceuticals to Use Excess Cash to Repurchase Stock and Increase Stockholder ValueNovember 22, 2010Pharma News - Business Wire
Amag Pharma Cutting 68 JobsNovember 01, 2010Xconomy Life Sciences
AMAG Pharmaceuticals Dives On Drug Safety WoesOctober 29, 2010Health News - Fox Business
AMAG to cut staff by 24%, reports safety issues for kidney drugOctober 29, 2010FierceBiotech
AMAG Pharmaceuticals, Inc. Finds Safety Issues With Kidney Drug, Feraheme, Slashes Jobs by 24% October 29, 2010BioSpace
AMAG Pharmaceuticals Announces Financial Results for the Third Quarter Ended September 30, 2010 and a Restructuring Plan to Reduce Operating ExpensesOctober 28, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Third Quarter on October 28, 2010 at 5:30 p.m. ETOctober 22, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. Announces Data Presentations at the American Society of Nephrology (ASN) Renal Week MeetingOctober 21, 2010Pharma News - Business Wire
Investors Sell Off Shares of AMAG Pharmaceuticals, Down 2% (AMAG)October 08, 2010Biotechnology - Moreover
AMAG Falls On FDA Safety MeetingSeptember 21, 2010Health News - Fox Business
Look for Shares of AMAG Pharmaceuticals to Rebound after Yesterday's 6.68% Sell Off (AMAG)August 30, 2010Biotechnology - Moreover
Relatively High Sales Growth Detected in Shares of AMAG Pharmaceuticals in the Biotechnology Industry (AMAG, INCY, TRGT, SGEN, ACOR)August 27, 2010Biotechnology - Moreover
AMAG Pharmaceuticals, Inc. to Present at Canaccord Genuity 30th Annual Global Growth ConferenceAugust 03, 2010Pharma News - Business Wire
AMAG Slides On Earnings Report, DowngradeJuly 29, 2010Health News - Fox Business
AMAG Pharmaceuticals Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2010July 28, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Second Quarter on July 28, 2010 at 4:30 p.m. ETJuly 21, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. and Takeda Pharmaceutical Co. Ltd. Announce Acceptance of Submission of Feraheme(R) Marketing Authorization Application to the European Medicines Evaluation Agency June 29, 2010BioSpace - Breaking News
AMAG Pharmaceuticals and Takeda Announce Acceptance of Submission of Feraheme® Marketing Authorization Application to the European Medicines AgencyJune 29, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor ConferencesJune 04, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Present at the 2010 Citi Investment Research Global Healthcare ConferenceMay 20, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2010 Healthcare ConferenceMay 03, 2010Pharma News - Business Wire
BioCryst rallies on gout study; AMAG fallsApril 28, 2010Biotechnology - Moreover
AMAG Pharma shares fall on weak 1Q resultsApril 28, 2010Health News - CNBC
Amag shares fall after its earnings fall shortApril 27, 2010Health News - CNBC
AMAG Pharmaceuticals, Inc. Appoints Gary J. Zieziula as Executive Vice President and Chief Commercial OfficerApril 27, 2010Pharma News - Business Wire
AMAG Pharmaceuticals Announces First Quarter 2010 Financial ResultsApril 27, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Quarter Ended March 31, 2010April 21, 2010Pharma News - Business Wire
Investors Dump Shares of AMAG Pharmaceuticals, Down 0.6% (AMAG)April 16, 2010Biotechnology - Moreover
SS&C Prices IPO, Amag Gets $60M from Takeda, Selecta Nabs $15M, & More Boston-Area Deals NewsApril 07, 2010Xconomy Life Sciences
Imprivata Simplifies Password Management at AMAG PharmaceuticalsApril 06, 2010Marketwire - Pharma and Biotech
Sellers Distribute Shares of AMAG Pharmaceuticals, Down 2.8% (AMA...April 05, 2010Biotechnology - Moreover
Deal may help AMAG boost a bestseller’s salesApril 05, 2010Pharmaceutical - Moreover
Takeda, AMAG form licensing deal for anemia drug FerahemeApril 02, 2010Pharmaceutical - Moreover
Lexington’s Amag closes higher on dealApril 02, 2010Pharmaceutical - Moreover
Avila Gets Leukemia & Lymphoma Society Funding, Dicerna Unites with Ipsen, Rhythmia to Test Heart Mapping Technology, Amag Licenses to Takeda, & More Boston-Area Life Sciences NewsApril 02, 2010Xconomy Life Sciences
AMAG Pharma, Takeda Pharmaceutical Collaborate For FerahemeApril 01, 2010Pharmaceutical - Moreover
AMAG Pharmaceuticals, Inc. Enters into Anemia Drug Licensing Deal with Takeda Pharmaceutical Co. Ltd.; to Get $60 Million Upfront, Eligible for $220 Million in Milestone Payments April 01, 2010BioSpace
Amag Pharma Gets $60M Upfront in Licensing Deal with TakedaApril 01, 2010Xconomy Life Sciences
AMAG licenses Feraheme to Takeda in $280M dealApril 01, 2010Health News - CNBC
AMAG Pharmaceuticals and Takeda Pharmaceutical Company AnnounceApril 01, 2010Pharmaceutical - Moreover
AMAG Pharmaceuticals and Takeda Pharmaceutical Company Announce Strategic Collaboration for Feraheme(R) in All Therapeutic Indications in Select Ex-US Territories, Including EuropeApril 01, 2010Pharmaceutical - Moreover
AMAG Pharmaceuticals and Takeda Pharmaceutical Company Announce Strategic Collaboration for Feraheme® in All Therapeutic Indications in Select Ex-US Territories, Including EuropeApril 01, 2010Pharma News - Business Wire
AMAG Pharmaceuticals to Host Conference Call to Discuss Strategic Collaboration with Takeda Pharmaceutical Company for Feraheme® in Select Ex-US TerritoriesApril 01, 2010Pharma News - Business Wire
Abraham, Fruchter & Twersky, LLP Warns Investors That It is the Only Law Firm That Has Filed a Class Action Lawsuit Against AMAG Pharmaceuticals, Inc.March 25, 2010Pharma News - Business Wire
AMAG Pharmaceuticals under Investigation for Potentially Defrauding Shareholders, Says Hagens BermanMarch 25, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. Announces Data Presentation at the National Kidney Foundation (NKF) 2010 Spring Clinical MeetingMarch 16, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Present at the Cowen and Company 30th Annual Healthcare ConferenceMarch 02, 2010Pharma News - Business Wire
AMAG Pharmaceuticals Announces Fourth Quarter and Year End 2009 Financial ResultsMarch 01, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2009February 22, 2010FDA News - Business Wire
Use of AMAG's Feraheme is on the Rise with 23% of Nephrologists Reporting Use of the ProductFebruary 16, 2010Biotech News - PR Newswire
AMAG Pharmaceuticals, Inc. Safety Update on Anemia Drug February 08, 2010BioSpace
AMAG Pharmaceuticals Provides Feraheme® Safety UpdateFebruary 05, 2010Pharma News - Business Wire
AMAG Pharma prices, expands stock offeringJanuary 21, 2010Health News - BizJournals.com
AMAG Pharmaceuticals Announces Pricing of Public Offering of 3,600,000 Shares of Common StockJanuary 21, 2010Pharma News - Business Wire
Amag Pharma to Sell 3M SharesJanuary 20, 2010Xconomy Life Sciences
AMAG Pharmaceuticals Announces Proposed Offering of 3,000,000 Shares of Common StockJanuary 19, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Present at the 28th Annual J.P. Morgan Healthcare ConferenceJanuary 05, 2010Pharma News - Business Wire
AMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of DirectorsPharma News - Business Wire
AMAG Pharmaceuticals, Inc. to Present at the Deutsche Bank 2009 Biotech Boston Confab ConferenceFDA News - Business Wire
AMAG Pharmaceuticals, Inc. to Present at the Deutsche Bank 2009 Biotech Boston Confab ConferenceFDA News - Business Wire



View all the latest news